Atinary Technologies is expanding its collaboration with Takeda Pharmaceuticals, the largest pharmaceutical company in Japan. The launch in Boston of the Atinary Lab, the Self-driving LaboratoryTM, is a leap toward reshaping the future of R&D with AI-driven, automated workflows in drug discovery and advanced chemistry.

Atinary Technologies正在扩大与日本最大制药公司武田制药（Takeda Pharmaceuticals）的合作。自动驾驶实验室TM（Auto-drivingLaboratoryTM）在波士顿的推出是一次飞跃，它通过人工智能驱动的药物发现和高级化学自动化工作流程重塑了研发的未来。

Atinary Lab will bring to life the unparalleled potential of SDLabsTM, Atinary’s no-code AI platform, alongside cutting-edge autonomous technology..

Atinary实验室将为Atinary的无代码AI平台SDLabsTM带来无与伦比的潜力，以及尖端的自主技术。。

Located in Kendall Square, Cambridge, the Atinary Lab will serve as a demonstration hub, allowing Takeda to experience firsthand the powerful synergies of AI, automation, and robotics in optimizing laboratory workflows to tackle complex challenges, and accelerate R&D. This pioneering lab is more than just a step toward the future of digital R&D: it will generate large, high-quality, reproducible, and machine learning-ready (ML-ready) datasets to continually refine Atinary’s algorithms, including large language models (LLM), transfer learning, and multi-fidelity learning.

位于剑桥肯德尔广场的Atinary实验室将作为一个示范中心，使武田能够亲身体验人工智能、自动化和机器人技术在优化实验室工作流程以应对复杂挑战和加速研发方面的强大协同作用。这个开创性的实验室不仅仅是迈向数字研发未来的一步：它将生成大型、高质量、可重复和机器学习就绪（ML就绪）数据集，以不断完善Atinary的算法，包括大型语言模型（LLM）、迁移学习和多保真学习。

By implementing these transformative technologies, the Atinary Lab will showcase the lab of the future, equipped to solve some of the most complex challenges in R&D..

通过实施这些变革性技术，实验室将展示未来的实验室，能够解决研发中一些最复杂的挑战。。

This expanded collaboration builds on the initial projects between Atinary and Takeda launched in 2023. The initial results, driven by Atinary's ML algorithms and orchestrated in SDLabs demonstrated increases in yields from under 50% to above 90%, after only 3 closed loop cycles or iterations (link to webinar)..

这种扩大的合作建立在Atinary和武田于2023年启动的初始项目的基础上。由Atinary的ML算法驱动并在SDLabs中协调的初步结果表明，仅经过3个闭环循环或迭代（链接到网络研讨会），产量就从50%以下提高到90%以上。。

The Atinary Lab will leverage Takeda’s expertise to design the workflow and define the lab equipment specifications. Atinary will be responsible for constructing the lab, providing the AI and ML expertise and tools, software engineering resources, and technical talent to integrate robotic platforms and analytic equipment in needed to execute the seamless operation of the self-driving lab..

实验室将利用武田的专业知识设计工作流程并定义实验室设备规格。Atinary将负责建造实验室，提供AI和ML专业知识和工具、软件工程资源以及技术人才，以整合机器人平台和分析设备，从而实现自动驾驶实验室的无缝运行。。

The lead investor to fund the inaugural Atinary Lab's construction is AgFunder, the deep tech venture capitalist with roots in agriculture, AI, and biology. AgFunder was the lead investor in Atinary's seed round in 2023.

为首次实验室建设提供资金的主要投资者是AgFunder，这是一家深技术风险投资家，植根于农业、人工智能和生物学。AgFunder是2023年Atinary种子轮的主要投资者。

Key Features of the Atinary Lab:

实验室的主要特点：

High-Throughput and Low-Throughput Self-Driving Workflows: Initial case studies focusing various classes of small molecule reaction workflows.

高通量和低通量自动驱动工作流程：针对各类小分子反应工作流程的初步案例研究。

Self-driving Data Factory: The Atinary Lab will feature AI-driven Design of Experiments (AI-DoE), automated reaction screening, and advanced data analytics, all integrated seamlessly into automated workflows to generate high-quality, reproducible, and ML-ready datasets.

自动驱动数据工厂：实验室将采用人工智能驱动的实验设计（AI-DoE），自动反应筛选和高级数据分析，所有这些都无缝集成到自动化工作流程中，以生成高质量，可重复和ML就绪的数据集。

Advanced Connectivity: A critical aspect of the Atinary Lab will be connectivity and communication between different hardware and software systems, allowing AI to drive and orchestrate experiments with minimal human intervention.

先进的连通性：实验室的一个关键方面是不同硬件和软件系统之间的连通性和通信，使人工智能能够在最少的人为干预下驱动和协调实验。

'The launch of Atinary’s Self-driving LabTM is a significant step forward in demonstrating the lab of the future that can run 24/7. The goal is to produce the datasets and tools needed for exponential R&D that can increase success rates and bring breakthrough molecules and solutions to market much faster,' said Dr.

“Atinary的自动驾驶实验室TM的推出是展示未来实验室可以全天候运行的重要一步。“我们的目标是生产指数级研发所需的数据集和工具，以提高成功率，并更快地将突破性的分子和解决方案推向市场，”Dr。

Hermann Tribukait, Co-Founder and CEO of Atinary Technologies..

Hermann Tribukait，Atinary Technologies联合创始人兼首席执行官。。

Dr. Adrian Ramirez, Senior Lab Automation Scientist at Takeda, stated that 'this technology eliminates the tedious repetitive manual tasks, minimizes human error and biases and maximizes efficiency across complex laboratory workflows. This project positions Atinary and Takeda as leading innovators in the rapidly evolving AI-driven experimentation for drug development.

。该项目将Atinary和武田定位为快速发展的人工智能驱动的药物开发实验的领先创新者。

In 10-15 years, I envision that lab scientists will not need to run many experiments anymore.'.

在10-15年内，我设想实验室科学家将不再需要进行许多实验。”。

Manuel Gonzalez, Partner at AgFunder further stated that “Atinary is revolutionizing R&D with its AI-driven automation and pioneering Self-driving LabTM technology. By building a fully Self Driving LabTM, Atinary is taking innovation to new heights, streamlining complex workflows, and unlocking unparalleled possibilities in materials and drug discovery.

AgFunder合伙人曼努埃尔·冈萨雷斯（ManuelGonzalez）进一步表示，“Atinary正在通过其人工智能驱动的自动化和开创性的自动驾驶LabTM技术彻底改变研发。通过构建一个完全自动驾驶的LabTM，Atinary正在将创新推向新的高度，简化复杂的工作流程，并在材料和药物发现方面释放无与伦比的可能性。

It’s inspiring to be part of a journey that isn’t just pushing the boundaries of what’s possible, but actively redefining them.”(ES).

成为一段旅程的一部分是令人鼓舞的，这段旅程不仅要突破可能的界限，还要积极地重新定义它们。”（ES）。

0Comments

0注意事项

Back to all news

返回所有新闻

Please login

请登录

or sign up

或注册

to comment.

发表评论。

Commenting guidelines

评论指南

Send

发送